Unknown

Dataset Information

0

Antiviral antibodies are necessary for control of simian immunodeficiency virus replication.


ABSTRACT: To better define the role of B cells in the control of pathogenic simian immunodeficiency virus (SIV) replication, six rhesus monkeys were depleted of B cells by intravenous infusion of rituximab (anti-CD20) 28 days and 7 days before intravaginal SIVmac239 inoculation and every 21 days thereafter until AIDS developed. Although the blood and tissues were similarly depleted of B cells, anti-SIV immunoglobulin G (IgG) antibody responses were completely blocked in only three of the six animals. In all six animals, levels of viral RNA (vRNA) in plasma peaked at 2 weeks and declined by 4 weeks postinoculation (PI). However, the three animals prevented from making an anti-SIV antibody response had significantly higher plasma vRNA levels through 12 weeks PI (P = 0.012). The remaining three B-cell-depleted animals made moderate anti-SIV IgG antibody responses, maintained moderate plasma SIV loads, and showed an expected rate of disease progression, surviving to 24 weeks PI without developing AIDS. In contrast, all three of the B-cell-depleted animals prevented from making anti-SIV IgG responses developed AIDS by 16 weeks PI (P = 0.0001). These observations indicate that antiviral antibody responses are critical in maintaining effective control of SIV replication at early time points postinfection.

SUBMITTER: Miller CJ 

PROVIDER: S-EPMC1900210 | biostudies-literature | 2007 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Antiviral antibodies are necessary for control of simian immunodeficiency virus replication.

Miller Christopher J CJ   Genescà Meritxell M   Abel Kristina K   Montefiori David D   Forthal Donald D   Bost Kristen K   Li Jun J   Favre David D   McCune Joseph M JM  

Journal of virology 20070228 10


To better define the role of B cells in the control of pathogenic simian immunodeficiency virus (SIV) replication, six rhesus monkeys were depleted of B cells by intravenous infusion of rituximab (anti-CD20) 28 days and 7 days before intravaginal SIVmac239 inoculation and every 21 days thereafter until AIDS developed. Although the blood and tissues were similarly depleted of B cells, anti-SIV immunoglobulin G (IgG) antibody responses were completely blocked in only three of the six animals. In a  ...[more]

Similar Datasets

| S-EPMC2698536 | biostudies-literature
| PRJNA317777 | ENA
| PRJNA640803 | ENA
| PRJNA69627 | ENA
| PRJNA176620 | ENA
| S-EPMC2212812 | biostudies-literature
| S-EPMC3911762 | biostudies-literature
| S-EPMC2772717 | biostudies-literature
| S-EPMC3416303 | biostudies-literature
| S-EPMC2566295 | biostudies-literature